Actively Recruiting
Valvular Heart Disease in Women Registry
Led by Valvular Heart Disease in Women Registry · Updated on 2025-09-29
800
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
Sponsors
V
Valvular Heart Disease in Women Registry
Lead Sponsor
E
European Association of Cardiovascular Imaging
Collaborating Sponsor
AI-Summary
What this Trial Is About
Valvular heart disease (VHD) is a significant global health concern affecting many people worldwide. This research aims to study gender differences in VHD, including disparities in risks, diagnosis, and treatment. The study will recruit both men and women to examine how gender affects care from hospital admission to the first outpatient follow-up, addressing inequalities in medical and socioeconomic factors and treatment delivery. This is an observational registry enrolling adult patients diagnosed with any valvular heart disease according to current European Society of Cardiology (ESC) guidelines. Participants will be grouped by gender, either women or men with VHD, and followed over time without receiving any specific interventions. The study focuses on monitoring adherence to guidelines and timing of care rather than testing treatments. Participants will be tracked from hospital admission through their first outpatient visit. Researchers will collect data on treatment disparities, management differences, and compliance with ESC guidelines over one year. Outcomes include timing from diagnosis to therapy, symptom onset to presentation, and procedural complications. This registry will help understand gender-based differences in VHD care and guide future improvements.
CONDITIONS
Brief Title
Valvular Heart Disease in Women Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with diagnosis of any valvular heart disease according to current ESC guidelines
- Admission to the VHD-W Registry collaborating center
You will not qualify if you...
- Age less than 18 years old
- Inability to provide informed consent per local institutional and regulatory requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At admission
Participants undergo diagnostic evaluations for valvular heart disease at the time of hospital admission, either elective or urgent.
1 visit (in-person)
Duration - Up to 1 year
Participants are observed for gender differences in valvular heart disease treatment and management from admission up to the first outpatient follow-up.
1 follow-up visit (in-person)
Trial Site Locations
Total: 2 locations
1
Aswan Heart Centre
Aswān, Egypt
Actively Recruiting
2
University of Lisbon
Lisbon, Portugal
Actively Recruiting
Research Team
S
Shehab Anwer, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here